A survey on COVID-19 vaccine complication in India
Keywords:
survey COVID-19, vaccine complication, IndiaAbstract
Objectives- The objective of this survey is to find the various Covid-19 vaccine complication in India and to spread awareness among people about adverse effects and their reporting also to study the rare side effects so to minimize the chances to harmful effects. Methods-Online surveys and questionnaires have been used to collect data from various peoples or subjects. Key findings- Majorly mild adverse effects have been reported, very few severe cases had reported and no rare side effect have been found in this survey. Adverse events those who have been found during the clinal trails had reported no new adverse reported in population of survey involved. Conclusion- The vaccine that have been administered by the population are safer but some precautionary measure must be taken and special attention to be given for elderly person and pregnant ladies and those who are already having any health-related issues while vaccinating them.
Downloads
References
Alexis, Beatty, Noah.D, Peyser, “Analysis of Covid-19 vaccine type and adverse effects following vaccination”, December 22,2021, JAMA network
Choudhary.O.P., Choudhary.P, Singh.I, “India’s Covid-19 vaccination drive: key challenges and resolution”, published on September 13,2021.
Covid vaccine: India administers more than one billion covid jabs, published by BBC News on October 21,2021- https://www.bbc.com/news/world-asia-india-56345591
Das.U., Rathore.U., Pal.R, Reasearh Paper on Willingness to pay for Covid-19 vaccine: a case study from India, published on Taylor&Francis.
Desai.D, Khan.A. R, Soneja.M, Mittal.A. “Effectiveness of an inactivated virus-based on SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study, Elsevier ltd.
Dr.Kucharke.V.G., Dr. Kale.R.H, Dr. Biyani.K.R., Shinde.S. D, ‘A Textbookof Pharmacological Screening Method’, published by PeeVee publication, page no.,74-75
Estofolete.C. F, Banho.C.A. A, Campos. G.R.F, Marquees’. “Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in Corona Vaccinees in Brazil
India rolls out the world’s largest Covid-19 vaccination drive, January 16,2021
Intriago, C. Z., & Posligua, T. I. Q. (2020). Telecommunications and virtualization in times of pandemic: impact on the electrical engineering career. International Journal of Physical Sciences and Engineering, 4(3), 38–44. https://doi.org/10.29332/ijpse.v4n3.630
Jeong.M “Global Covid-19 vaccine summary: Side effects”, September 2021, Medical news today.
Jha.N, Palaian.S, Shankar.P. R, Dangal. G, “Pharmacovigilance of Covid-19 vaccines in the context of Nepal: an assessment based on early adverse drug reaction reports, published on Journal of Pharmaceutical Health Services Research, published on 12 April ,2021
Kaur.R. J, Charan.J, Dutta.S, Dhingra S, Bhardwaj.P, Mitra.P, Yadav.D, Sharma P, Singh K, Misra.S, “Adverse Events Reported from Covid-19 Vaccine Trails: A Systemic Review”, published by springer, published on 27 March, 2021
Kraus.P. R, Fleming.T.R. R, Peto.R, Longini.I.M, “Considerations in boosting Covid-19 vaccine immune responses, Lancet 2019;398:1377-80
Langhe, “Covid-19 Vaccine Trials are a case study on the challenges of data literacy”, published on 11 December,2020 by Harvard Business Review
Nugraha, I. S., & Udi, W. W. (2022). The corelation of pharmaceutical services with the incidence of side effects of phase III COVID vaccination participants in RS Tingkat II Udayana. International Journal of Health & Medical Sciences, 5(4), 260-266. https://doi.org/10.21744/ijhms.v5n4.1944
Rajpurohit.P, Suva.M, Rajpurohit.H, Singh.Y, Boda.P, Research Article on Retrospective observational survey of adverse events following immunization comparing tolerability of Covishield and Covaxin vaccines in the real world published on Journal of Pharmacovigilance and Drug Research
Restricted Use of Covaxin under Clinical Trial Mode, published by Bharat Biotech lead Innovation, dated on 11-01-2021
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Tartof.S. Y, Slezak.J.M, Fischer.H, “Effectiveness of mRNA BNT162b2 Covid-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study”, Elsevier ltd.
Thiruvengadam.R, Awasthi. A, Maldigesting, “Cellular Immune Responses are Preserved and may Contribute to ChAdOx1 nCoV-19 vaccine Effectiveness Against infection due to SARS-CoV-2 B.1.617.2 Delta Variant Despite Reduced Virus Neutralization
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
